Hemispherx Biopharma Appoints Two Senior Pharma Executives to Key Manufacturing Positions

February 4, 2010 |

1 min read

PHILADELPHIA, Feb. 4, 2010 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company") announced today the appointments of Dr. Christopher Cavalli and Mr. Robert Fidanza.

People

MORE ON THIS TOPIC

Creative collage illustration of financial business. Two businessmen shaking hands for partners agreement. Conceptual illustration of success deal, corporate ethic, connection.

Weight loss

Zealand Bets up to $2.5B in Metabolic Pact With Chinese Biotech

December 11, 2025

·

2 min read

·

Tristan Manalac

Pictured: Pfizer's signage outside its office in Canada/iStock, JHVEPhoto

Layoffs

Pfizer’s Cost Cuts Claim 200+ Jobs in Switzerland: Report

December 11, 2025

·

2 min read

·

Tristan Manalac

Closeup of businessman give money to robot. Man pass banknote bribe to robotic assistant. AI and technology. Vector illustration.

Immunology and inflammation

Novartis Unites With Relation in $1.7B Inflammatory Skin Disease Pact

December 9, 2025

·

2 min read

·

Tristan Manalac

Microscope icon. Molecule and communication background. Connected lines with dots.

China

With Chinese Assets in Hand, Pharma Is Wondering What Else Can Be Learned

December 9, 2025

·

3 min read

·

Annalee Armstrong